Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Share News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LiDCO surges on positive clinical trials

Wed, 05th Jun 2013 12:30

AIM-listed cardiovascular monitoring company LiDCO Group, has revealed that its LiDCOrapid blood monitoring system has been used successfully to monitor patients having major liver surgery. The hemodynamic system monitored cardiac output and guided intravenous fluid therapy in a randomised clinical trial on enhanced recovery versus standard care following open liver resection.The company reported that the clinical trial had involved 91 patients who were randomly allocated to receive standard care or an enhanced recovery programme (ERP) and the patients in the ERP were monitored using the LiDCOrapid system.Overall, the trial confirmed that using an ERP that included goal directed fluid therapy (GDFT) monitored by the LiDCOrapid system reduced the length of stay by three days for patients undergoing open liver resection and post-operative complications were reduced to 7.0% versus 27% in the control arm. This better care had led to "an improvement in short term quality of life for the patients in the ERP GDFT arm of the trial", the company said.LiDCOrapid uses a specific algorithm derived from the analysis of the pulse power of the arterial waveform to calculate the stroke volume from the heart. Terry O'Brien, Chief Executive Officer of LiDCO, said: "This study adds to the performance and outcomes evidence base supporting the advantages for use of the LiDCO's monitoring technology in high risk surgery patients." He added: "The ease of use of the system by healthcare professionals and benefits for patients gives us confidence that the LiDCOrapid system has the performance necessary to establish itself as the fluid monitoring system of choice in the fluid optimisation of high risk surgery patients both during and after major surgery." LiDCO Group's share price was up 10.39% to 10.62p at 11:54 on Wednesday.MF
More News
12 Feb 2014 10:53

LiDCO Expects To Swing To Pretax Profit In Full Year, As Expected

LONDON (Alliance News) - LiDCO Group PLC Wednesday said it expects pretax profit for the year ended January 31 to be in line with expectations, compared with a loss of GBP260,000 a year earlier. In a trading update ahead of its full-year results, the cardiovascular monitoring company said r

Read more
12 Feb 2014 08:25

UK MORNING BRIEFING: Telecity Drops 13% As Market Awaits BOE

LONDON (Alliance News) - Shares have opened mostly flat Wednesday, as the market awaits the Bank of England's Quarterly Inflation Report at 1030 GMT.

Telecity is holding back the FTSE 250. The data-centre provider is down 13% after announcing higher 2013 profit and

Read more
1 Oct 2013 08:47

LiDCO cash-flow positive as losses come down in first half

Surgical blood monitoring group LiDCO said it expected to be cash generative and profitable in the full year after slashing losses in the first half. Chief Executive Officer Terry O'Brien said the company had seen significant sales growth in the UK and export markets in the six months to end-July

Read more
26 Sep 2013 08:18

LiDCO Granted Graphical User Interface Patent By US Patent Office

Read more
4 Sep 2013 10:35

LiDCO receives approval from FDA

LiDCO, a cardiovascular monitoring company, said Wednesday that the US Food and Drug Administration (FDA) has cleared its CNSystems' continuous non-invasive blood pressure monitoring module for sale. The software enables the connection of modules to the LiDCOrapid cardiac output monitor allowing i

Read more
4 Sep 2013 09:13

LiDCo Says Blood Pressure System Using Its Montior Gets FDA Clearance

Read more
4 Sep 2013 08:18

STOCKS NEWS EUROPE-UK small caps outperform wider market

UK small caps and junior-listed AIM shares trade flat and up 0.1 percent respectively, outperforming the wider market where the mid-caps shed 0.6 percent and the blue chips trade 0.2 percent weaker. AIM-listed cardiovascular monitoring firm LiDCO Group advances almost 5 percent after the c

Read more
5 Jun 2013 16:09

STOCKS NEWS EUROPE-UK small caps fall less than broader market

The FTSE small-cap index and the junior FTSE Alternative Investment Market (AIM) all-share index both end 1.3 percent lower, outperforming a 1.8 percent fall for the mid caps and a 2.1 percent drop on the blue chips. Shares in VPhase fall 44 percent to 0.26 pence as the AIM-listed energy ef

Read more
17 Dec 2012 07:45

LiDCO drives US expansion

Cardiovascular monitoring company LiDCO confirmed that it has acquired the existing LiDCOrapid customer base from Covidien, its previous US distribution partner, as it beefs up commercial opportunities in the US. After an initial integration and switch-over period the group expects associated rev

Read more
23 Aug 2012 16:00

Small caps round-up: Infrastructure India, SkyePharma, LiDCO Group

Infrastructure India, an AIM-listed investment group, pleased its investors with a 50.2 per cent leap in its net asset value (NAV) to 207.3m pounds over the year ended March. The value of the company's investments rose 94.9 per cent to 216.7m pounds, while the NAV per share climbed from 92p to 95p.

Read more
24 Apr 2012 15:52

LiDCO posts maiden profit

LiDCO, the blood movement monitoring company, announced its maiden post-tax profit although phasing issues with a major customer meant the numbers were not as impressive as the market had been expecting. The company made a loss of £45,000 before tax in the year to January 31st, versus a loss of £49

Read more
27 Oct 2011 06:54

Thursday tips round-up: BATs, CSR, Lidco...

British American Tobacco, the world's second-biggest maker of cigarettes, yesterday delivered a smoking set of results for the first nine months of this year, writes the Investment Column in the Independent. The volume of cigarettes sold by the group slipped by 0.4 per cent but BAT's ability to push

Read more
23 Aug 2011 13:58

LiDCO's sales to grow 18%

Cardiovascular monitoring company LiDCO expects revenue in the six months ended 31 July to be 18% ahead of the first half of 2010. The firm predicts sales to be at least £3.1m, compared to the £2.66m reported the year before, while losses are said to have been "significantly reduced". Pre-tax losse

Read more
20 Jul 2011 17:04

Premier Farnell director buys after shares wither

Premier Farnell non-executive director Paul Withers has taken advantage of a recent weak spell in the electrical components and industrial products supplier's share price, spending nearly £55,000. He took 30,000 shares at 183p a go, and now has 70,000. Shares in Premier Farnell took a dive earlier

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.